» Articles » PMID: 27165587

[Efficacy of Different Preparations of Budesonide Combined with Pulmonary Surfactant in the Treatment of Neonatal Respiratory Distress Syndrome: a Comparative Analysis]

Overview
Specialty Pediatrics
Date 2016 May 12
PMID 27165587
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the efficacy of different preparations of budesonide combined with pulmonary surfactant (PS) in improving blood gas levels and preventing bronchopulmonary dysplasia (BPD) in preterm infants with neonatal respiratory distress syndrome (NRDS).

Methods: A total of 184 preterm infants who developed NRDS within 4 hours after birth were randomly administered with PS + continuous inhalation of budesonide aerosol (continuous aerosol group), PS+budesonide solution (solution group), PS + single inhalation of budesonide aerosol (single aerosol group), and PS alone, with 46 neonates in each group. The changes in arterial blood gas levels, rate of invasive mechanical ventilation after treatment, time of assisted ventilation, rate of repeated use of PS, and the incidence of BPD were compared between the four groups.

Results: On the 2nd to 4th day after treatment, pH, PCO2, and oxygenation index (FiO2/PaO2) showed significant differences among the four groups, and the continuous aerosol group showed the most improvements of all indicators, followed by the solution group, single aerosol group, and PS alone group. The continuous aerosol group had a significantly shorter time of assisted ventilation than the other three groups (P<0.05). The solution group had a significantly shorter time of assisted ventilation than the single aerosol and PS alone groups (P<0.05). The rate of invasive mechanical ventilation after treatment, rate of repeated use of PS, and incidence of BPD showed significant differences among the four groups (P<0.05), and the continuous aerosol group had the lowest rates, followed by the solution group.

Conclusions: A combination of PS and continuous inhalation of budesonide aerosol has a better efficacy in the treatment of NRDS than a combination of PS and budesonide solution. The difference in reducing the incidence of BDP between the two administration methods awaits further investigation with a larger sample size.

Citing Articles

Efficacy of pulmonary surfactant with budesonide in premature infants: A systematic review and meta-analysis.

Phattraprayoon N, Tan B, Takuathung M PLoS One. 2025; 20(1):e0312561.

PMID: 39787118 PMC: 11717239. DOI: 10.1371/journal.pone.0312561.


The Care of Preterm and Term Newborns with Respiratory Conditions: A Systematic Synthesis of Evidence from Low- and Middle-Income Countries.

Dominguez G, Muralidharan O, Lee Him R, Harrison L, Vaivada T, Bhutta Z Neonatology. 2024; 122(Suppl 1):152-172.

PMID: 39541964 PMC: 11875421. DOI: 10.1159/000542482.


Meta-analysis of the efficacy of budesonide and ambroxol hydrochloride inhalation in children with pneumonia and their effects on inflammatory response.

Shen H, Zhao X, Xu L Heliyon. 2023; 9(11):e21105.

PMID: 37954384 PMC: 10637922. DOI: 10.1016/j.heliyon.2023.e21105.


A systematic review and meta-analysis of pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome.

Yi Z, Tan Y, Liu Y, Jiang L, Luo L, Wang L Transl Pediatr. 2022; 11(4):526-536.

PMID: 35558978 PMC: 9085948. DOI: 10.21037/tp-22-8.


Effect of different maintenance doses of caffeine citrate on ventilator weaning in very preterm infants with respiratory distress syndrome: a prospective randomized controlled trial.

Li X, Cai Y, Zhang Z, Li J, Chen X, Song Y Zhongguo Dang Dai Er Ke Za Zhi. 2021; 23(11):1097-1102.

PMID: 34753540 PMC: 8580023. DOI: 10.7499/j.issn.1008-8830.2107167.


References
1.
Carvalho C, Silveira R, Procianoy R . Ventilator-induced lung injury in preterm infants. Rev Bras Ter Intensiva. 2014; 25(4):319-26. PMC: 4031878. DOI: 10.5935/0103-507X.20130054. View

2.
Mazela J, Polin R . Aerosol delivery to ventilated newborn infants: historical challenges and new directions. Eur J Pediatr. 2010; 170(4):433-44. PMC: 3059826. DOI: 10.1007/s00431-010-1292-6. View

3.
Slaughter J, Stenger M, Reagan P, Jadcherla S . Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia. PLoS One. 2014; 9(9):e106838. PMC: 4156388. DOI: 10.1371/journal.pone.0106838. View

4.
Kuo H, Lin H, Tsai C, Chouc I, Yeh T . A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants. J Pediatr. 2010; 156(4):537-41. DOI: 10.1016/j.jpeds.2009.10.049. View

5.
Yang C, Lin C, Chiou S, Yang Y, Tsao P, Lee Y . Intratracheal budesonide supplementation in addition to surfactant improves pulmonary outcome in surfactant-depleted newborn piglets. Pediatr Pulmonol. 2012; 48(2):151-9. DOI: 10.1002/ppul.22564. View